Karen Akinsanya Schrodinger, Inc. (SDGR) insider trading activity

SDGR Quotes by TradingView

Karen Akinsanya is President of R&D, Therapeutics of Schrodinger, Inc.. Currently has a direct ownership of 0 shares of SDGR, which is worth approximately $0. The most recent transaction as insider was on Oct 15, 2021, when has been sold 1,393 shares (Common Stock) at a price of $55.75 per share, resulting in proceeds of $77,660. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
0% 12M change
Total Value Held $0

Karen Akinsanya Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 15 2021
SELL
Open market or private sale
$77,660 $55.75 p/Share
1,393 Reduced 100.0%
0 Common Stock
Oct 15 2021
BUY
Exercise of conversion of derivative security
$6,046 $4.34 p/Share
1,393 Added 50.0%
1,393 Common Stock
Sep 15 2021
SELL
Open market or private sale
$85,215 $61.13 p/Share
1,394 Reduced 100.0%
0 Common Stock
Sep 15 2021
BUY
Exercise of conversion of derivative security
$6,050 $4.34 p/Share
1,394 Added 50.0%
1,394 Common Stock
Aug 16 2021
SELL
Open market or private sale
$2,181,256 $57.8 p/Share
37,738 Reduced 100.0%
0 Common Stock
Aug 16 2021
BUY
Exercise of conversion of derivative security
$309,074 $8.19 p/Share
37,738 Added 50.0%
37,738 Common Stock
Jun 08 2021
SELL
Open market or private sale
$776,241 $75.79 p/Share
10,242 Reduced 100.0%
0 Common Stock
Jun 08 2021
BUY
Exercise of conversion of derivative security
$44,450 $4.34 p/Share
10,242 Added 50.0%
10,242 Common Stock
Jun 07 2021
SELL
Open market or private sale
$486,573 $75.1 p/Share
6,479 Reduced 100.0%
0 Common Stock
Jun 07 2021
BUY
Exercise of conversion of derivative security
$28,119 $4.34 p/Share
6,479 Added 50.0%
6,479 Common Stock
Dec 18 2020
SELL
Open market or private sale
$1,070,160 $80.0 p/Share
13,377 Reduced 100.0%
0 Common Stock
Dec 18 2020
BUY
Exercise of conversion of derivative security
$43,074 $3.22 p/Share
13,377 Added 50.0%
13,377 Common Stock

Also insider at

NAUT
Nautilus Biotechnology, Inc. Healthcare
Director
KA

Karen Akinsanya

President of R&D, Therapeutics
New York, NY

Track Institutional and Insider Activities on SDGR

Follow Schrodinger, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SDGR shares.

Notify only if

Insider Trading

Get notified when an Schrodinger, Inc. insider buys or sells SDGR shares.

Notify only if

News

Receive news related to Schrodinger, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SDGR